Tygh Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-24,796
Closed -$4.82M 95
2021
Q1
$4.82M Buy
24,796
+965
+4% +$198K 0.68% 65
2020
Q4
$4.57M Sell
23,831
-58,536
-71% -$10.6M 0.71% 66
2020
Q3
$12.2M Sell
82,367
-128
-0.2% -$18.3K 2.3% 7
2020
Q2
$10.2M Sell
82,495
-47,196
-36% -$5.55M 2.13% 11
2020
Q1
$12.5M Buy
129,691
+666
+0.5% +$64.3K 2.81% 4
2019
Q4
$11.9M Sell
129,025
-22,003
-15% -$1.85M 1.97% 13
2019
Q3
$11.6M Sell
151,028
-262
-0.2% -$22.9K 2.06% 14
2019
Q2
$13M Buy
151,290
+15,840
+12% +$1.08M 2.21% 9
2019
Q1
$8M Buy
135,450
+34
+0% +$1.96K 1.41% 30
2018
Q4
$7.14M Buy
135,416
+5,375
+4% +$315K 1.5% 24
2018
Q3
$7.21M Buy
130,041
+25,332
+24% +$1.31M 1.18% 35
2018
Q2
$4.93M Buy
+104,709
New +$4.31M 0.83% 58

Other funds holding RGEN

Tygh Capital Management's RGEN Position: Q2 2021 in Review

Tygh Capital Management sold out of Repligen (RGEN) in Q2 2021, closing a stake of 24,796 shares — an estimated $4.82M sold.

Tygh Capital Management first reported a position in RGEN in Q2 2018 and held it in 12 quarters. The position peaked at $13M in Q2 2019. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • Tygh Capital Management reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
  • Tygh Capital Management sold 24,796 Repligen shares in Q2 2021, an estimated $4.82M.
  • Tygh Capital Management first reported a position in Repligen in Q2 2018 and held it in 12 quarters.
  • Tygh Capital Management's Repligen position peaked at $13M in Q2 2019.
  • 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on Tygh Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.